The global micropump market is slated to attain a market valuation of USD 12.8 billion by 2033, registering a CAGR of 18.4%. Given below are some market propellants
| Data Points | Key Statistics |
|---|---|
| Estimated Value of Market by 2033 | USD 12.8 billion |
| Documented Market Value in 2022 | USD 1.94 billion |
| Estimated CAGR from 2023 to 2033 | 18.4% |
Micropumps are prominently used by biotechnology & pharmaceutical companies, hospitals & diagnostic centers, and academic & research institutes. Increased product application in these industries is projected to enhance the expansion prospects in the micropump industry in the upcoming years.
Micropumps are used for hormone treatment, pain and wound-care management, and injection of glucose and drugs. Moreover, some new therapies developed for curing cancer that require the implementation of micropump sets are propelling the market growth.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
In the historical period, the micropump market generated a revenue of USD 0.66 billion in 2017. The market exhibited a CAGR of 23.9% from 2017 to 2022, reaching a market valuation of USD 1.94 billion in 2022.
The demand for micropumps is rising to deal with the dynamic requirements of the medical industry. These micro-electro-mechanical systems (MEMS) help address personalized medication regimens, dosing schedules, intricately combined treatments, and much more.
Additionally, the growing consumer cognizance regarding the value of controlled drug delivery is also fueling the market growth.
In the forecast period, the global market is projected to expand at a CAGR of 18.4%, lower than the CAGR witnessed in the preceding years. The reduction in CAGR is reflected in countries across the globe.
The high production cost of micropumps and stringent laws regarding the use of micropump in the human healthcare system can be linked to the market’s reduced growth. The market is expected to reach USD 12.8 billion by 2033.
| Attribute | Valuation |
|---|---|
| 2025 | USD 3.36 billion |
| 2028 | USD 5.58 billion |
| 2032 | USD 10.97 billion |
| Historical CAGR (2017 to 2022) | 23.9% |
|---|---|
| Forecast CAGR (2023 to 2033) | 18.4% |
North America is predicted to be the leading region in the global micropump market. The regional growth can be attributed to the presence of top companies that are focusing on research and development of novel technologies to be used in the medical sector.
The United States is the leading country in North America as well as globally in the production and export of micropumps used in various sectors.
Moreover, the growing awareness about the importance of controlled drug delivery is anticipated to drive the regional market. The presence of advanced healthcare infrastructure and early adoption of advanced technologies propel the growth of the micropump market in North America.
Rising Incidents of Chronic, as well as Contagious Diseases, to boost the Market
There has been a significant rise in disease burden in the healthcare sectors worldwide. It has also led to an increase in the consumption of drugs in recent years. But the complexity of newly emerging diseases and the degrading health of the aged population has increased the demand for using several powerful drugs in appropriate quantities.
The need for a precise drug delivery method has emerged to be the prominent micropump application that has created immense opportunities for micropump manufacturers.
These innovative kinds of micropumps are of miniature dimensions ranging up to micrometers. The development and facilitation of microelectromechanical (MEM) technology systems have allowed for the manufacturing of high-precision micropump and turned out to be the most precise method for drug industries.
With the advancement of technology, these miniature fluid delivery devices are reducing in size and are optimized for higher efficiency. The traditional micropump that was widely used by drug manufacturing companies was replaced by new advances in the market.
Development of Advanced Micropumps to Meet the Growing Demand for Micropumps
Advanced versions developed by micropump manufacturers like Cole-Parmer Instrument Company, LLC., and IDEX have secured a brand value for themselves in the United States market.
As the transfer of an accurate amount of fluid is easily achieved with the help of a waterway micropump, its uses have increased in many areas of medical services. Transdermal insulin delivery and blood transportation through the artificial heart are some of the new services besides the injection of drugs and glucose carried out by the use of micropumps.
To cater to a huge demand for micropumps, manufacturers have developed different types of micropumps under different names. Micropump GB series and Micropump GA series are some famous categories of the micropump in the global market.
Principal Consultant
In 2022, North America dominated the global micropump market by occupying a significant share in terms of revenue. North America is predicted to be the leading region in the global market during the forecast period.
The presence of top companies focusing on research and development of novel technologies is the primary reason for regional growth. The United States is the leading country in North America as well as globally in the production and export of micropumps used in various sectors.
Europe follows North America in terms of revenue generation. The adoption of novel technologies in the healthcare sectors of several developed countries of Europe has made it the second-leading attractive region for micropump gear pump manufacturers.
The increasing government spending on building a robust research environment for biotechnology and medical sectors is further expected to boost the demand for valveless micropumps in the coming years.
The betterment of economic conditions in several countries of Asia Pacific has increased the spending on healthcare services. A growing number of hospitals and medical establishments is projected to significantly increase the demand for diaphragm micropumps to be used in drug delivery activities.
| Taxonomy | Product Type |
|---|---|
| Top Segment | Non-mechanical Micropump |
| Forecast CAGR | 17.9% |
| Taxonomy | Application |
|---|---|
| Top Segment | In-vitro Diagnostics |
| Forecast CAGR | 17.6% |
Based on end use, the market is categorized into biotechnology & pharmaceutical companies, hospitals & diagnostic centers, and academic & research institutes. The hospitals and diagnostic centers segment accounts for a significant market share.
The high-pressure micropumps are prominently used in hospitals and diagnostic centers for delivering drugs from the reservoir to tissue and blood vessels in accurate amounts, this boosts the growth of the segment. Advancement in medical science is also projected to aid segment growth.
Based on product type, mechanical micropumps and non-mechanical micropumps are the two groups of micropumps provided by micropump manufacturers in the global market.
The non-mechanical micropumps segment is more popular than the mechanical micropump segment, attaining a CAGR of 17.9% over the forecast period. This segment is predicted to have favorable growth opportunities under its easy-to-use mechanism that can be utilized by aged people for personalized medication.
| Historical CAGR (2017 to 2022) | 23.2% |
|---|---|
| Forecast CAGR (2023 to 2033) | 17.9% |
In-vitro diagnostics is projected to hold a significant share of the total demand for micropumps in the global market. The segment is expected to attain a CAGR of 17.6% in the forecast period. Surging utilization of mechanical as well as non-mechanical pumps primarily in in-vitro diagnostics is predicted to enhance segment growth.
| Historical CAGR (2017 to 2022) | 22.8% |
|---|---|
| Forecast CAGR (2023 to 2033) | 17.6% |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Country | The United States |
|---|---|
| CAGR (2023 to 2033) | 18.2% |
| Market Size (2033) | USD 4.5 billion |
| Country | The United Kingdom |
|---|---|
| CAGR (2023 to 2033) | 17.4% |
| Market Size (2033) | USD 538.7 million |
| Country | China |
|---|---|
| CAGR (2023 to 2033) | 17.8% |
| Market Size (2033) | USD 918.5 million |
| Country | Japan |
|---|---|
| CAGR (2023 to 2033) | 16.8% |
| Market Size (2033) | USD 750.7 million |
| Country | India |
|---|---|
| CAGR (2023 to 2033) | 16% |
| Market Size (2033) | USD 441.6 million |
| Attributes | Details |
|---|---|
| Market Size (2033) | USD 4.5 billion |
| Market Absolute Dollar Growth (USD million/billion) | USD 3.7 billion |
The United States micropump market is gearing up to keep its momentum going to ensure its dominant position over the next 10 years. The regional market is projected to attain USD 4.5 billion by 2033, depicting a CAGR of 18.2% in the meantime. From 2017 to 2022, the market has been expanding at a robust CAGR of 23.5%.
The market growth can be attributed to the early adoption of advanced technologies in the region. Factors such as the high count of key companies and the availability of modern healthcare infrastructure are also augmenting the market in the United States.
The widening geriatric population base and surging incidences of chronic diseases detected among people in America are boosting the sale of micropumps.
| Historical CAGR (2017 to 2022) | 23.5% |
|---|---|
| Forecast CAGR (2023 to 2033) | 18.2% |
| Attributes | Details |
|---|---|
| Market Size (2033) | USD 538.7 million |
| Market Absolute Dollar Growth (USD million/billion) | USD 430.4 million |
The United Kingdom is anticipated to hold a significant market share in the Europe region over the upcoming years. As per the latest FMI analysis, the United Kingdom is predicted to attain USD 538.7 million by 2033.
The market, in the meanwhile, is projected to register a CAGR of 17.4%. Previously, from 2017 to 2022, the micropump market demonstrated a CAGR of 22.4%. The large population size in the United Kingdom that requires significant diagnosis and proficient medical assistance is catering to the market development.
The introduction of advanced micropumps by key manufacturers operating in the country is augmenting the market growth. The newly developed Disc Pump technology by LEE Ventus offers many benefits.
These benefits include silent operation, unrivaled pressure, and flow, lightweight and compact, ultra-low pulsatility output, full control flexibility, etc. Upcoming technological upgrades in the product portfolio by key players are projected to assist market growth.
| Historical CAGR (2017 to 2022) | 22.4% |
|---|---|
| Forecast CAGR (2023 to 2033) | 17.4% |
| Attributes | Details |
|---|---|
| Market Size (2033) | USD 918.5 million |
| Market Absolute Dollar Growth (USD million/billion) | USD 739.4 million |
China micropump market is gearing up to achieve a market valuation of USD 918.5 million by 2033. The market is projected to grow at a CAGR of 17.8% over the forecast period. The robust pace acquired by China market, although lower than the United States, can be attributed to the surging heart and cancer patients in the country.
The growing importance of micropumps, especially for their microfluidic applications, is pushing the market forward. Moreover, the latest research and development activities in the realm of micropump technology are projected to facilitate market growth over the forecast period.
| Historical CAGR (2017 to 2022) | 23.1% |
|---|---|
| Forecast CAGR (2023 to 2033) | 17.8% |
| Attributes | Details |
|---|---|
| Market Size (2033) | USD 750.7 million |
| Market Absolute Dollar Growth (USD million/billion) | USD 591.7 million |
Japan is following behind China in the Asia Pacific region. The country is set to attain USD 750.7 million, as per the new estimates by Future Market Insights. Japan micropump market is predicted to expand at a CAGR of 16.8% over the forecast period. In the historical period, the market documented a CAGR of 21.9%.
In recent years, the robust growth of microscale and sub-millimeter engineering has led to the development of miniaturized devices and systems. Many advantages offered by miniaturized devices like micropumps including higher speed, portability, lower sample volume, etc., have been boosting their demand among end users.
| Historical CAGR (2017 to 2022) | 21.9% |
|---|---|
| Forecast CAGR (2023 to 2033) | 16.8% |
Key players operating in the market are investing in research and development activities to develop novel technologies that extend the application so micropumps. Additionally, companies are also employing merger and acquisition, and collaboration strategies to further expand the market base for micropumps in emerging economies.
Recent Developments Achieved by Micropump Industry
| Attribute | Details |
|---|---|
| Market Size Value in 2023 | USD 2.4 billion |
| Market Forecast Value in 2033 | USD 12.8 billion |
| Global Growth Rate | 18.4% |
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | USD billion/million for Value |
| Key Regions Covered | North America; Latin America; Europe; Asia Pacific; The Middle East and Africa |
| Key Countries Covered | The United States, Brazil, Mexico, Canada, the United Kingdom, Germany, France, Spain, Italy, Russia, Argentina, Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, Singapore, Thailand, Vietnam, Australia, Poland, China, New Zealand, Japan, North Africa, GCC countries, Ethiopia, South Africa, others |
| Key Market Segments Covered | Product Type, Application, End User, Region |
| Key Companies Profiled | LEE Ventus; Sensile Medical; Cole-Parmer India Pvt Ltd, IDEX; Dolomite Microfluidics; The Lee Company; Gardner Denver; Takasago Electric, Inc.; Halma Plc; Servoflo Corporation |
| Pricing | Available upon Request |
The global micropump market is expected to progress at 18.4% CAGR until 2033.
The overall micropump market is projected to reach around USD 12.8 billion by 2033.
Based on product types, the non-mehnical micropumps sales are poised to increase at 17.9% CAGR through 2033.
China dominates the Asia Pacific market and is projected to advance at 17.8% CAGR through 2033.
Use of micropumps in hospitals and diagnostic centers constitutes the leading segment.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Mechanical Micropump 5.1.1. Piezoelectric Micropump 5.1.2. Peristaltic Micropump 5.1.3. Others 5.2. Non-mechanical Micropump 6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application 6.1. Drug Delivery 6.2. In-Vitro Diagnostics 6.3. Medical Devices 6.4. Others 7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 7.1. Biotechnology & Pharmaceutical Companies 7.2. Hospitals & Diagnostic Centres 7.3. Academic & Research Institutes 8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region 8.1. North America 8.2. Latin America 8.3. Europe 8.4. Asia Pacific 8.5. Middle East and Africa 9. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 10. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 11. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 12. Asia Pacific Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 13. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 14. Key Countries Market Analysis 15. Market Structure Analysis 16. Competition Analysis 16.1. TTP Ventus 16.2. Sensile Medical 16.3. Cole-Parmer India Pvt Ltd 16.4. IDEX 16.5. Dolomite Microfluidics 16.6. The Lee Company 16.7. Gardner Denver 16.8. Takasago Electric, Inc. 16.9. Halma Plc 16.10. Servoflo Corporation 17. Assumptions & Acronyms Used 18. Research Methodology
Explore Healthcare Insights
View Reports
Micropump Market
